Dr. Lal Path Labs Shareholding Pattern
- Market cap
- ₹32,569 crore
- P/E
- 60.1
- P/B
- 12.99
- ROE
- 21.6%
- Dividend yield
- 0.46%
As of 30-JUN-2026, promoters held 53.19% of Dr. Lal Path Labs (-0.02 pp from 31-MAR-2026), foreign institutional investors 17.36%, domestic institutions 21.59%, the government 0.01% and the public 7.47%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Dr. Lal Path Labs shareholding pattern — frequently asked questions
What is the promoter holding in Dr. Lal Path Labs?
Promoters held 53.19% of Dr. Lal Path Labs as of 30-JUN-2026, down 0.02 pp from 53.21% in 31-MAR-2026.
How much do FIIs hold in Dr. Lal Path Labs?
Foreign institutional investors held 17.36% of Dr. Lal Path Labs as of 30-JUN-2026, a change of +0.18 pp from the previous quarter.
How much do domestic institutions hold in Dr. Lal Path Labs?
Domestic institutional investors, including mutual funds and insurers, held 21.59% of Dr. Lal Path Labs as of 30-JUN-2026 (+0.21 pp from the previous quarter).
Who owns Dr. Lal Path Labs?
As of 30-JUN-2026, Dr. Lal Path Labs' shareholders were promoters (53.19%), foreign institutional investors 17.36%, domestic institutions 21.59%, the government 0.01% and the public 7.47%, as filed with the stock exchanges.
Same Data For Peers
Trade Dr. Lal Path Labs With ATS
Track LALPATHLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.